Abstract

Docosahexaenoyl ethanolamide (DHEA), the ethanolamine conjugate of the n-3 long chain polyunsaturated fatty acid docosahexaenoic acid, is endogenously present in the human circulation and in tissues. Its immunomodulating properties have been (partly) attributed to an interaction with the cyclooxygenase-2 (COX-2) enzyme. Recently, we discovered that COX-2 converts DHEA into two oxygenated metabolites, 13- and 16-hydroxylated-DHEA (13- and 16-HDHEA, respectively). It remained unclear whether these oxygenated metabolites also display immunomodulating properties like their parent DHEA. In the current study we investigated the immunomodulating properties of 13- and 16-HDHEA in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. The compounds reduced production of tumor necrosis factor alpha (TNFα), interleukin (IL)-1β and IL-1Ra, but did not affect nitric oxide (NO) and IL-6 release. Transcriptome analysis showed that the compounds inhibited the LPS-mediated induction of pro-inflammatory genes (InhbA, Ifit1) and suggested potential inhibition of regulators such as toll-like receptor 4 (TLR4), MyD88, and interferon regulatory factor 3 (IRF3), whereas anti-inflammatory genes (SerpinB2) and potential regulators IL-10, sirtuin 1 (Sirt-1), fluticasone propionate were induced. Additionally, transcriptome analysis of 13-HDHEA suggests a potential anti-angiogenic role. In contrast to the known oxylipin-lowering effects of DHEA, liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) analyses revealed that 13- and 16-HDHEA did not affect oxylipin formation. Overall, the anti-inflammatory effects of 13-HDHEA and 16-HDHEA are less pronounced compared to their parent molecule DHEA. Therefore, we propose that COX-2 metabolism of DHEA acts as a regulatory mechanism to limit the anti-inflammatory properties of DHEA.

Highlights

  • Long chain n-3 polyunsaturated fatty acids (LC-PUFAs) are essential for neural development and functioning, and have been linked to certain beneficial health effects

  • docosahexaenoyl ethanolamide (DHEA) is endogenously present in the circulation and tissues in humans and animals [15,20,21,22,23,24,25], and its levels are generally increased after docosahexaenoic acid (DHA) intake, for example by consumption of n-3 fatty acid-containing products such as fatty fish or fish oil supple­ ments [15,20,22,26]

  • We demonstrated that purified COX-2 converts DHEA into 13- and 16-HDHEA, and we confirmed its formation in 1.0 μg/mL LPS-stimulated RAW264.7 macrophages (Fig. 1) [38]

Read more

Summary

Introduction

Long chain n-3 polyunsaturated fatty acids (LC-PUFAs) are essential for neural development and functioning, and have been linked to certain beneficial health effects. The potential health effects of n-3 LCPUFAs are continuously being challenged by new studies. Suggested explanations for these apparent discrepancies are differences in the level of intake or administered dose, and the study population [1]. Increased dietary DHA intake alters the cell membrane composition leading to a higher n-3 content This change in membrane composition leads to a decreased production of pro-inflammatory n-6 oxylipins and increases the pro­ duction of potent inflammation resolving n-3 oxylipins including resolvins, protectins, and maresins [1,11,15,16,17,18,19]. DHEA inhibits neuroinflammation via interac­ tion with the GPR110 [28,30], and reduces the production of inflam­ mation markers like monocyte chemoattractant protein 1 (MCP-1), NO, IL-6, and prostaglandin E2 (PGE2) in LPS-stimulated RAW264.7 mac­ rophages and 3T3-L1 adipocytes [1,29,31,32,33]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.